MedTrace Logo

Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months

NCT00711737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2011-06-17

No results posted yet for this study

Summary

The purpose of this study is to explore the changes in metabolic parameters in patients treated with escitalopram for six months for major depression, generalized anxiety disorder or panic disorder, with or without agoraphobia.

Conditions

Sponsors & Collaborators

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • Lai H Peh, MBBS · Changi General Hospital

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00711737 on ClinicalTrials.gov